Exceptions were observed for participants taking cholesterol lowering medication (Q-risk score, F (1, 53) = 5.88, p = .02; M ± SD, yes = 23.54 ± 12.89, no = 13.87 ± 12.87), medication for hypertension (ESR, F (1, 58) = 4.49, p = .04; M ± SD, yes = 1.23 ± 0.33, no = 0.97 ± 0.39; LDL-C, F (1, 58) = 4.13, p = <.05; M ± SD, yes = 0.54 ± 0.11, no = 0.60 ± 0.09; and plasma glucose, F (1, 59) = 10.41, p = <.01; M ± SD, yes = 0.73 ± 0.12, no = 0.66 ± 0.04), and anti-TNF therapy (functional disability, F (1, 58) = 5.85, p = .02; M ± SD, yes = 1.47 ± 0.14, no = 1.25 ± 0.22). Here, TNF is linked to hypertensive disorder.